DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) Shareholders’ equity
DRUGS MADE IN AMERICA ACQUISITION II CORP. (DMIIR) shareholders’ equity at each fiscal year-end, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to DMIIRSource: SEC XBRL filings · For reference only · Not investment advice
More DMIIR financial trends
DMIIR RevenueDMIIR Net incomeDMIIR Net marginDMIIR Gross profitDMIIR Gross marginDMIIR Operating incomeDMIIR Operating marginDMIIR Operating cash flowDMIIR Free cash flowDMIIR Capital expendituresDMIIR Return on equityDMIIR Stock buybacksDMIIR Dividends paidDMIIR Total assetsDMIIR Total liabilitiesDMIIR overview →